Literature DB >> 20070942

Aggravated experimental autoimmune encephalomyelitis in IL-15 knockout mice.

Diego Gomez-Nicola1, Alessandra Spagnolo, Carmen Guaza, Manuel Nieto-Sampedro.   

Abstract

IL-15 initially identified as a T proliferating cytokine has several structural and biological similarities with IL-2 and has been associated with a number of autoimmune diseases. Because of the scarcity of information available on the role of IL-15 in MS pathogenesis, we have investigated how the absence of IL-15 affected the development of experimental autoimmune encephalomyelitis, a mouse model of MS. Following immunization of IL-15(-/-) and C57BL/6 mice with MOG(35-55), we observed a more severe neurological impairment in the IL-15 knockout mice than in the wild-type group. The enhanced disease severity in IL-15(-/-) mice was associated with greater demyelination in the spinal cord, increased immune cell infiltration and inflammation. These events may be related to the higher CD4/CD8 ratio and the almost absent NK cell activity, congenital immune features of IL-15KO mice. Moreover, we found that the fractalkine receptor CX3CR1 was overexpressed in the spinal cord of IL-15(-/-) mice, mainly localized on infiltrating CD8(+) T cells. How these findings are contributing to the aggravated EAE development in IL-15 KO mice remain unclear and need to be further investigated. Copyright 2009 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20070942     DOI: 10.1016/j.expneurol.2009.12.034

Source DB:  PubMed          Journal:  Exp Neurol        ISSN: 0014-4886            Impact factor:   5.330


  19 in total

Review 1.  The role of B cells in multiple sclerosis: Current and future therapies.

Authors:  Austin Negron; Rachel R Robinson; Olaf Stüve; Thomas G Forsthuber
Journal:  Cell Immunol       Date:  2018-10-21       Impact factor: 4.868

2.  IL-15 suppresses colitis-associated colon carcinogenesis by inducing antitumor immunity.

Authors:  Rajia Bahri; Ioannis S Pateras; Orietta D'Orlando; Diego A Goyeneche-Patino; Michelle Campbell; Julia K Polansky; Hilary Sandig; Marilena Papaioannou; Kostas Evangelou; Periklis G Foukas; Vassilis G Gorgoulis; Silvia Bulfone-Paus
Journal:  Oncoimmunology       Date:  2015-01-22       Impact factor: 8.110

3.  IL-15 receptor α signaling constrains the development of IL-17-producing γδ T cells.

Authors:  Sara L Colpitts; Lynn Puddington; Leo Lefrançois
Journal:  Proc Natl Acad Sci U S A       Date:  2015-07-20       Impact factor: 11.205

4.  CD4 effector T cell differentiation is controlled by IL-15 that is expressed and presented in trans.

Authors:  Adam T Waickman; Davinna L Ligons; SuJin Hwang; Joo-Young Park; Vanja Lazarevic; Noriko Sato; Changwan Hong; Jung-Hyun Park
Journal:  Cytokine       Date:  2017-08-12       Impact factor: 3.861

5.  The role of IL-15 in activating STAT5 and fine-tuning IL-17A production in CD4 T lymphocytes.

Authors:  Pushpa Pandiyan; Xiang-Ping Yang; Senthil S Saravanamuthu; Lixin Zheng; Satoru Ishihara; John J O'Shea; Michael J Lenardo
Journal:  J Immunol       Date:  2012-09-19       Impact factor: 5.422

6.  Potential protective role of IL15Rα during inflammation.

Authors:  Weihong Pan; Xiaojun Wu; Abba J Kastin; Yan Zhang; Hung Hsuchou; Franz Halberg; Finla Chatu; Reas S Khan; Barry Robert; Germaine G Cornelissen-Guillaume
Journal:  J Mol Neurosci       Date:  2010-10-28       Impact factor: 3.444

Review 7.  The Multiple Roles of B Cells in Multiple Sclerosis and Their Implications in Multiple Sclerosis Therapies.

Authors:  Rui Li; Amit Bar-Or
Journal:  Cold Spring Harb Perspect Med       Date:  2019-04-01       Impact factor: 6.915

8.  Amelioration of arthritis through mobilization of peptide-specific CD8+ regulatory T cells.

Authors:  Jianmei W Leavenworth; Xiaolei Tang; Hye-Jung Kim; Xiaoyang Wang; Harvey Cantor
Journal:  J Clin Invest       Date:  2013-02-08       Impact factor: 14.808

9.  Deficiency of interleukin-15 enhances susceptibility to acetaminophen-induced liver injury in mice.

Authors:  Hsein-San Hou; Ching-Len Liao; Huey-Kang Sytwu; Nan-Shih Liao; Tien-Yu Huang; Tsai-Yuan Hsieh; Heng-Cheng Chu
Journal:  PLoS One       Date:  2012-09-18       Impact factor: 3.240

10.  Cellular sources of dysregulated cytokines in relapsing-remitting multiple sclerosis.

Authors:  Jeppe Romme Christensen; Lars Börnsen; Dan Hesse; Martin Krakauer; Per Soelberg Sørensen; Helle Bach Søndergaard; Finn Sellebjerg
Journal:  J Neuroinflammation       Date:  2012-09-14       Impact factor: 8.322

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.